Intuitive surgical today
Intuitively understandable surgical
As of 04.25.2025 21:00
- 52-week range
- $ 367.39
▼
$ 616.00
- P/e ratio.
- 80.28
- Value is valuable
- $ 598.95
Intuitive Surgical Inc. shares NASDAQ: ISRG They are aligned after some changeable price movement around the quarterly income of the company. On April 22, the Robotics surgery company delivered be on the top and outcomeNevertheless, the company offered a mixed leadership with the possibility of higher volumes that compensate for the uncertainty about the tariff policy of the Trump administration.
Investors know this Movement at the price of shares Around the income can be unstable. This is especially true in relation to ISRG Stock. At a trading session before the report, ISRG shares were shot 8% higherBut this quickly returned most of these benefits after the report was released after the market was closed.
However, in the following days after the company’s report, investors overestimated him, and the shares are trying to rise higher, although below what it was made before the company reported.
Even with a double blow, the company announced mixed income
Finding numbers for intuitive surgeons were firm. A $ 1.81 Profit per share (EPS) It is easy to beat estimates for 10 cents and 20% above last year (YOY). The same applies to income. 2.25 billion dollars. USA received in the quarter Increased estimates by 3.27% And came 19% higher the year.
Double strikes, as a rule, lead to an increase in promotions, but with tariffs on the consciousness of many investors, the leadership of an intuitive surgical surgical language will receive a significant analysis. The company expects to see an increased increase in volume for procedures. For example, he expects the number of procedures from customers using their DA Vinci systems will increase by 15-17%. This was higher than the previous management of the company in growth from 13% to 16%.
Tariffs compensate for this growthNevertheless, the company can provide only limited management in this regard.
Complex prospects for the tariff
On the one hand, the management reported that in 2024, 98% of its Davinci systems were manufactured in the United States. However, 70% of the company’s endoscopes were made in EuropeAnd approximately 80% of its tools and accessories were made in Mexico.
Even more complicating the picture, intuitive surgical sources of raw materials and other components that are included in these products from many other countries. This reveals the company to three different tariff levels in its current state:
- China – The company is both an importer and an exporter. At the time of income report, this could to incur 125% and 145% of tariffsrespectively. The Trump administration made comments suggesting that the final numbers will not be so high, but each number is probably higher than at the previous level.
- Europe – intuitive surgical snacks components from approved suppliers and import endoscopes from their own European factories. They are subject to 10% basic tariffs This can become higher when the pause of the ninety -end, or when it is concluded in the trading transaction.
- Mexico – Some of the company’s products are not certified in accordance with the USMCA agreement and will be subjected to Current 25% of imported tariffsField
This illustrates the concern that investors experience from the current tariff situation. Intuitively understandable surgical Gross margin not GAAP from 65% to 66.5%Decrease about 5% year. This involves the estimated influence of 1.7% on revenue, plus or minus 30 basic points.
Participation in ISRG shares
Intuitive surgical forecast today
$ 598.95
16.39% growthModerate purchase
Based on 20 analysts ratings
| The current price | $ 514.59 |
|---|---|
| High forecast | $ 711.00 |
| Average forecast | $ 598.95 |
| Low forecast | $ 470.00 |
Intuitive details of the forecast of surgical reserve
IN 75.8x forward incomeThe company’s shares are expensive relatively wider market and other medical actions, but not to a five -year -old average. Over the past five years, this award has not interfered with shareholders. ISRG Stock has grown. This is an encouraging sign that the shares seem to have Found support at about 485 dollarsField
Nevertheless, the shares are still traded below their 50- and 100-day simple sliding funds (SMA). With such great uncertainty related to tariffs, there is no good reason to believe that shares in the short term will rise sharply.
On the other hand, investors saw what could happen with one remark from the current administration. The essence of investors is that a number of results are possible, and analysts reduce price indicators, although they still suggest that the action can grow by about 16%.
A Prospects for ISRG Stock As smooth as the tariff situation. This is why investors may want Wait for the action to break above the 50-day SMAOr fall clearly lower before taking up a long position.
Before considering an intuitive surgical surgical, you will want to hear it.
Marketbeat monitors the highest and most effective analysts with the most effective Wall Street analysts and promotions that they recommend to their customers daily. Marketbeat has identified five shares that leading analysts quietly whisper to their clients to buy now before a wider market is won … and intuitively understandable surgical.
Although an intuitive surgical rating currently has a moderate purchase rating among analysts, analysts with the highest rating believe that these five promotions are better buying.
View five shares here
Want to know what will be the following actions that will be large, with solid grounds? Enter your email address to see which MarketBeat analysts can become the following blockbuster growth promotions.
Get this free report